The Chinese Market for Cancer Intervention

  • ID: 4327686
  • Report
  • Region: China
  • 130 Pages
  • BCC Research
15 % OFF
until Jun 30th 2018
1 of 6
The Chinese Cancer Intervention Market Should Reach $46.7 Billion in 2017 and $89.3 Billion by 2022, at a CAGR of 13.8% through 2022

FEATURED COMPANIES

  • Accuragen
  • Astrazeneca
  • Guangzhou Anchordx Llc
  • Hitachi Medical
  • MSD China
  • Sanofi
  • MORE

Report Includes

  • An overview of the Chinese market for cancer intervention.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Coverage of current procedures as well as those expected to be realized over the next five years.
  • Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Profiles of major players in the industry.

Report Scope

The scope of the report includes cancer intervention applications, industries, markets, and companies in China. The markets for cancer intervention are given for the years 2016, 2017 and 2022.

The Chinese cancer intervention market includes two major segments: cancer treatment and cancer diagnosis and detection. Each major segment will be further divided and discussed by technology, drug type, end user, etc.

In this report, China is referred to as Mainland China. It does not include Hong Kong, Macao and Taiwan. Mainland China has a total of 31 province-level regions, including 22 provinces, four province-level municipalities (cities), and five province-level autonomous regions. Important geographic markets will be discussed, including Beijing, Shanghai and others.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Accuragen
  • Astrazeneca
  • Guangzhou Anchordx Llc
  • Hitachi Medical
  • MSD China
  • Sanofi
  • MORE

1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown

2: Summary and Highlights

  • Largest Segments in the Chinese Cancer Intervention Market
  • Fastest Growing Segments in the Chinese Cancer Intervention Market
  • Table Summary : Chinese Market for Cancer Intervention, by Service Type, Through 2022
  • Figure Summary : Chinese Market for Cancer Intervention, by Service Type, 2016-2022

3: Market and Technology Background

  • Market Background
  • Technology Background

4: Market Breakdown by Technology Type

  • Antitumor Drugs
  • Immunopotentiators
  • Immunosuppressors
  • Adjuvant Drugs
  • Cancer Surgery
  • Radiotherapy
  • Diagnosis and Detection
  • Table 9 : Chinese Market for Cancer Intervention, by Major Segments, Through 2022
  • Figure 2 : Chinese Market for Cancer Intervention, by Major Segments, 2016-2022

5: Market Breakdown by Product

  • Drugs used for Cancer Treatment in China
  • Adjuvant Drugs
  • Cancer Surgery
  • Radiotherapy
  • Diagnosis and Detection
  • Table 17 : Chinese Market for Cancer Intervention, by Major Type, Through 2022
  • Figure 3 : Chinese Market for Cancer Intervention, by Major Type, 2016-2022
  • Table 18 : Chinese Market for Cancer Treatment, by Major Purpose, Through 2022

6: Market Breakdown by End Use

  • Chinese Lung Cancer Intervention Market
  • Chinese Gastric Cancer Intervention Market
  • Chinese Liver Cancer Intervention Market
  • Chinese Esophageal Cancer Intervention Market
  • Chinese Colorectal Cancer Intervention Market
  • Chinese Breast Cancer Intervention Market
  • Market of Other Cancer Types in China
  • Table 62 : Chinese Cancer Intervention Market, by Cancer Type, Through 2022

7: Market Breakdown by Region

  • East China Cancer Intervention Market
  • Middle China Cancer Intervention Market
  • North China Cancer Intervention Market
  • Southwest China Cancer Intervention Market
  • Northwest China Cancer Intervention Market
  • Northeast China Cancer Intervention Market
  • South China Cancer Intervention Market
  • Table 87 : Chinese Cancer Intervention Market, by Region, Through 2022
  • Figure 13 : Chinese Cancer Intervention Market, by Region, 2016-2022

8: Analysis of Market Opportunities

  • Reference Listed Drugs
  • Generic Drugs
  • Surgery Materials
  • Radiotherapy Equipment
  • DNA Sequencing
  • Traditional Chinese Drugs

9: Company Profiles

  • Accuragen
  • Accuray
  • Annoroad Gene Technology
  • Astellas
  • Astrazeneca
  • Bayer China Ltd.
  • Beijing Genetron Health Co. Ltd.
  • Beijing Genomics Institute
  • Beijing IPE Center
  • Beijing Sanvalley Technology Co. Ltd.
  • Beijing Sciecure Pharmaceutical Co. Ltd.
  • Beijing Sinomdgene Technology Co. Ltd.
  • Beijing Solomenbrothers Medical Technology Co. Ltd.
  • Bristol-Myers Squibb (China) Investment Co. Ltd.
  • Changbaishan Pharmaceutical Co. Ltd. (Changbaishan)
  • Chiatai Tianqing Pharmaceutical Group Co. Ltd.
  • CSPC Pharmaceutical Group Ltd.
  • Elekta Instrument Ab Stockholm
  • Fsens
  • Guangzhou Aic Biotechnologies Ltd
  • Guangzhou Anchordx Llc
  • Guangzhou Ezlife Bio Inc.
  • Guangzhou Forever Gen Bio-Technology Ltd.
  • Guizhou Yibai Pharmaceutical Co. Ltd. (Yibai)
  • Guoda Drugstore
  • Hainan Zhonghe Pharmaceutical Co. Ltd.
  • Hansoh
  • Hitachi Medical
  • Huadong Medicine Co. Ltd.
  • Huapont Life Sciences Co. Ltd.
  • Hybio Pharmaceutical Co. Ltd.
  • Jiangsu Hengrui Medicine Co. Ltd. (Hengrui)
  • Johnson & Johnson
  • Livzon Pharmaceutical Group Co. Ltd. (Livzon)
  • Lunan Pharmaceutical Group
  • Luye Pharma Group (Luye)
  • Masep Infini Medical Science Technology Co. Ltd.
  • MSD China
  • Novartis
  • Pfizer China
  • Qilu Pharmaceutical Co. Ltd.
  • Roche China
  • Sanofi
  • Sciclone Pharmaceuticals Inc.
  • Shanghai Bioasia Gene Co. Ltd.
  • Shenzhen Haplox Biotechnology Co. Ltd.
  • Shenzhen Yucebio Co. Ltd.
  • Sinopharm A-Think Pharmaceutical Co. Ltd. (A-Think)
  • Sinopharm Chuankang Pharmaceutical Co. Ltd. (Chuankang)
  • Sl Pharm
  • Taiho Pharma
  • Varian Medical Systems Inc.
  • Wuhan Hualong Bio-Chemical Pharmaceutical Co. Ltd.
  • Yatai Pharmaceuticals
  • Zhejiang Jiuxu Pharmaceutical Co. Ltd. (Jiuxu)
  • Zhejiang Kanglaite Pharmaceutical Co. Ltd. (Kanglaite)
  • Zhendong Group

10: Appendix: Glossary

  • Table 122 : Glossary/Abbreviations in this Report
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Accuragen
  • Astrazeneca
  • Guangzhou Anchordx Llc
  • Hitachi Medical
  • MSD China
  • Sanofi
  • MORE

Analyst Credentials:

Jason Chen has been an analyst and consultant for the polymer, composite, fiber, textile and energy industries for 15 years. He works as a researcher, writer and/or editor for the American Composites Manufacturers Association (ACMA), China Textile Academy (CTA), China Chemical Fiber Association (CCFA), International Fiber Journal, Filtration News, Platts Emission Daily, Vision Systems Design, Pesticide and Toxic Chemical News and MobileTex. Currently he is the chief scientist of a company endeavoring to reduce China's air and water pollution. He has a degree in Civil Engineering, Chemicals and Advanced Materials from Shantou University.

Note: Product cover images may vary from those shown
5 of 6
  • Accuragen
  • Accuray
  • Annoroad Gene Technology
  • Astellas
  • Astrazeneca
  • Bayer China Ltd.
  • Beijing Genetron Health Co. Ltd.
  • Beijing Genomics Institute
  • Beijing IPE Center
  • Beijing Sanvalley Technology Co. Ltd.
  • Beijing Sciecure Pharmaceutical Co. Ltd.
  • Beijing Sinomdgene Technology Co. Ltd.
  • Beijing Solomenbrothers Medical Technology Co. Ltd.
  • Bristol-Myers Squibb (China) Investment Co. Ltd.
  • Changbaishan Pharmaceutical Co. Ltd. (Changbaishan)
  • Chiatai Tianqing Pharmaceutical Group Co. Ltd.
  • CSPC Pharmaceutical Group Ltd.
  • Elekta Instrument Ab Stockholm
  • Fsens
  • Guangzhou Aic Biotechnologies Ltd
  • Guangzhou Anchordx Llc
  • Guangzhou Ezlife Bio Inc.
  • Guangzhou Forever Gen Bio-Technology Ltd.
  • Guizhou Yibai Pharmaceutical Co. Ltd. (Yibai)
  • Guoda Drugstore
  • Hainan Zhonghe Pharmaceutical Co. Ltd.
  • Hansoh
  • Hitachi Medical
  • Huadong Medicine Co. Ltd.
  • Huapont Life Sciences Co. Ltd.
  • Hybio Pharmaceutical Co. Ltd.
  • Jiangsu Hengrui Medicine Co. Ltd. (Hengrui)
  • Johnson & Johnson
  • Livzon Pharmaceutical Group Co. Ltd. (Livzon)
  • Lunan Pharmaceutical Group
  • Luye Pharma Group (Luye)
  • Masep Infini Medical Science Technology Co. Ltd.
  • MSD China
  • Novartis
  • Pfizer China
  • Qilu Pharmaceutical Co. Ltd.
  • Roche China
  • Sanofi
  • Sciclone Pharmaceuticals Inc.
  • Shanghai Bioasia Gene Co. Ltd.
  • Shenzhen Haplox Biotechnology Co. Ltd.
  • Shenzhen Yucebio Co. Ltd.
  • Sinopharm A-Think Pharmaceutical Co. Ltd. (A-Think)
  • Sinopharm Chuankang Pharmaceutical Co. Ltd. (Chuankang)
  • Sl Pharm
  • Taiho Pharma
  • Varian Medical Systems Inc.
  • Wuhan Hualong Bio-Chemical Pharmaceutical Co. Ltd.
  • Yatai Pharmaceuticals
  • Zhejiang Jiuxu Pharmaceutical Co. Ltd. (Jiuxu)
  • Zhejiang Kanglaite Pharmaceutical Co. Ltd. (Kanglaite)
  • Zhendong Group
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll